Early-onset Alzheimer disease in an Italian family with presenilin-1 double mutation E318G and G394V

被引:15
作者
Batelli, Sara [1 ]
Albani, Diego [1 ]
Prato, Francesca [1 ]
Polito, Letizia [1 ]
Franceschi, Massinio [2 ]
Gavazzi, Armando [2 ]
Forloni, Gianluigi [1 ]
机构
[1] Mario Negri Inst Pharmacol Res, Dept Neurosci, I-20157 Milan, Italy
[2] Multimed Santa Maria, Neurol Unit, Castellanza, Varese, Italy
关键词
Alzheimer disease; PSEN-1; E318G; G394V; amyloid beta-protein; neurogenetics; skin biopsy;
D O I
10.1097/WAD.0b013e31815a9dec
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The genetic form of Alzheimer disease (FAD) accounts for about 5% of total Alzheimer disease (AD) cases, and the discovery of FAD-linked genes has shed new light on AD pathogenic mechanism. The presenilins genes (PSEN-1 and PSEN-2) carry the large majority of FAD-linked mutations. Here, we report an Italian kindred with FAD and PSEN-1 double mutation E318G + G394V that clearly cosegregates with the pathology. The E318G mutation has not an assessed pathogenic function, but some data have highlighted a role as a risk factor for AD in a predisposed familiar background. The G394V mutation was still described in association to an AD case with reported (but not demonstrated) familiar cosegregation. In an attempt to better characterize the biochemical effect of this double mutation, we assessed A beta(1-40) and beta P(1-42) concentrations in conditioned media from primary skin fibroblasts obtained from AD-affected and healthy family members. We did not find any modification of the A beta(1-42)/A beta(1-40) ratio, suggesting that this double mutation might be involved in early-onset AD etiopathogenesis by affecting a PSEN-1 function other than gamma-secretase activity.
引用
收藏
页码:184 / 187
页数:4
相关论文
共 12 条
[1]  
ALBANI D, 2006, NEUROBIOL AGING
[2]   Presenilin clinical mutations can affect γ-secretase activity by different mechanisms [J].
Bentahir, M ;
Nyabi, O ;
Verhamme, J ;
Tolia, A ;
Horré, K ;
Wiltfang, J ;
Esselmann, H ;
De Strooper, B .
JOURNAL OF NEUROCHEMISTRY, 2006, 96 (03) :732-742
[3]   The current status of Alzheimer's disease genetics: what do we tell the patients? [J].
Bertram, L ;
Tanzi, RE .
PHARMACOLOGICAL RESEARCH, 2004, 50 (04) :385-396
[4]   PEN2 is not a genetic risk factor for Alzheimer's disease in a large family sample [J].
Bertram, L ;
Menon, R ;
Mullin, K ;
Parkinson, M ;
Bradley, ML ;
Blacker, D ;
Tanzi, RE .
NEUROLOGY, 2004, 62 (02) :304-306
[5]   Presenilin function and γ-secretase activity [J].
Brunkan, AL ;
Goate, AM .
JOURNAL OF NEUROCHEMISTRY, 2005, 93 (04) :769-792
[6]   Presenilin 1 deficiency alters the activity of voltage-gated Ca2+ channels in cultured cortical neurons [J].
Cook, DG ;
Li, XF ;
Cherry, SD ;
Cantrell, AR .
JOURNAL OF NEUROPHYSIOLOGY, 2005, 94 (06) :4421-4429
[7]   PEN-2 gene mutation in a familial Alzheimer's disease case [J].
Frigerio, CS ;
Piscopo, P ;
Calabrese, E ;
Crestini, A ;
Campeggi, LM ;
di Fava, RC ;
Fogliarino, S ;
Albani, D ;
Marcon, G ;
Cherchi, R ;
Piras, R ;
Forloni, G ;
Confaloni, A .
JOURNAL OF NEUROLOGY, 2005, 252 (09) :1033-1036
[8]   Presenifin 1 Glu318Gly polymorphism - Interpret with caution [J].
Goldman, JS ;
Johnson, JK ;
McElligott, K ;
Suchowersky, O ;
Miller, BL ;
Van Deerlin, VM .
ARCHIVES OF NEUROLOGY, 2005, 62 (10) :1624-1627
[9]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
[10]   Screening for PS1 mutations in a referral-based series of AD cases - 21 Novel mutations [J].
Rogaeva, EA ;
Fafel, KC ;
Song, YQ ;
Medeiros, H ;
Sato, C ;
Liang, Y ;
Richard, E ;
Rogaev, EI ;
Frommelt, P ;
Sadovnick, AD ;
Meschino, W ;
Rockwood, K ;
Boss, MA ;
Mayeux, R ;
St George-Hyslop, P .
NEUROLOGY, 2001, 57 (04) :621-625